Skip to main content

Table 1 Baseline participant characteristics

From: Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status

 IBD (n = 24)Non-IBD Controls (n = 20)Pvalue
Age (mean +/− range)45 (19–90)56 (22–88)0.045
Female:Male7:1711:90.153
Co-morbid illnesses, n (%)
Type 2 diabetes mellitus23 
Chronic kidney disease10 
Atrial fibrillation10 
Ischaemic heart disease12 
Colorectal adenocarcinoma01 
Other cancer13 
Body mass index (mean +/− range)26.9 (17.6–51.3)26.5 (5.43)0.866
Haemoglobin (g/L, mean, range)121 (62–153)124 (86–162)0.597
MCV (10−15L, mean, range)82 (55–96)81 (68–88)0.601
Serum ferritin (ng/mL, mean, range)30 (3–93)25 (7–62)0.395
White cell count (×  109/L, mean, range)7.6 (4.0–10.9)6.8 (3.7–21.4)0.416
Platelet count (× 109/L, mean, range)318 (150–680)237 (143–366)0.009
eGFR (mL/min/1.73m2, mean, range)85 (38 - > 90)80 (45- > 90)0.273
Serum albumin (g/L, mean, range)35 (25–48)38 (30–50)0.064
Serum C-reactive protein (mg/L, median, range)3 (< 2–18)< 2 (< 2–15)0.228
Faecal calprotectin (μg/g, median, range)573 (< 15- > 3000)47 (< 15–300)0.023
25(OH) vitamin D (nmol/L, mean, range)51 (8–104)49 (20–96)0.822
1,25(di-OH) vitamin D (pmol/L, mean, range)112 (50–202)136 (62–263)0.109
Serum calcium (corrected, mmol/L, mean ± 95% CI)2.40 (2.29–2.49)2.36 (2.21–2.55)0.115
Serum phosphate (mmol/L, mean ± 95% CI)1.11 (0.69–1.39)1.09 (0.63–1.60)0.700
Serum parathyroid hormone (pmol/L, mean ± 95% CI)5.1 (1.9–12.1)6.3 (1.4–11.5)0.103
  1. Unpaired t-test unless otherwise specified
  2. Chi-square